128 related articles for article (PubMed ID: 12235519)
1. Engraftment syndrome in children undergoing autologous peripheral blood progenitor cell transplantation.
Madero L; Vicent MG; Sevilla J; Prudencio M; Rodríguez F; Díaz MA
Bone Marrow Transplant; 2002 Sep; 30(6):355-8. PubMed ID: 12235519
[TBL] [Abstract][Full Text] [Related]
2. Engraftment syndrome after autologous peripheral blood progenitor cell transplantation in pediatric patients: a prospective evaluation of risk factors and outcome.
González-Vicent M; Ramírez M; Sevilla J; Pérez A; Fernández S; Madero L; Díaz MA
Bone Marrow Transplant; 2004 Dec; 34(12):1051-5. PubMed ID: 15516943
[TBL] [Abstract][Full Text] [Related]
3. Engraftment syndrome after autologous hematopoietic stem cell transplant supported by granulocyte-colony-stimulating factor (G-CSF) versus granulocyte-macrophage colony-stimulating factor (GM-CSF).
Akasheh M; Eastwood D; Vesole DH
Bone Marrow Transplant; 2003 Jan; 31(2):113-6. PubMed ID: 12621492
[TBL] [Abstract][Full Text] [Related]
4. Peripheral blood stem cell mobilization by granulocyte colony-stimulating factor alone and engraftment kinetics following autologous transplantation in children and adolescents with solid tumor.
Watanabe H; Watanabe T; Suzuya H; Wakata Y; Kaneko M; Onishi T; Okamoto Y; Abe T; Kawano Y; Kagami S; Takaue Y
Bone Marrow Transplant; 2006 Apr; 37(7):661-8. PubMed ID: 16489358
[TBL] [Abstract][Full Text] [Related]
5. Randomized comparison of granulocyte colony-stimulating factor versus granulocyte-macrophage colony-stimulating factor plus intensive chemotherapy for peripheral blood stem cell mobilization and autologous transplantation in multiple myeloma.
Arora M; Burns LJ; Barker JN; Miller JS; Defor TE; Olujohungbe AB; Weisdorf DJ
Biol Blood Marrow Transplant; 2004 Jun; 10(6):395-404. PubMed ID: 15148493
[TBL] [Abstract][Full Text] [Related]
6. Incidence, predisposing factors, and outcome of engraftment syndrome in pediatric allogeneic stem cell transplant recipients.
Schmid I; Stachel D; Pagel P; Albert MH
Biol Blood Marrow Transplant; 2008 Apr; 14(4):438-44. PubMed ID: 18342786
[TBL] [Abstract][Full Text] [Related]
7. Cytoreduction of lymphoid malignancies and mobilization of blood hematopoietic progenitor cells with high doses of cyclophosphamide and etoposide plus filgrastim.
Damon L; Rugo H; Tolaney S; Navarro W; Martin T; Ries C; Case D; Ault K; Linker C
Biol Blood Marrow Transplant; 2006 Mar; 12(3):316-24. PubMed ID: 16503501
[TBL] [Abstract][Full Text] [Related]
8. Clinical benefits of granulocyte colony-stimulating factor therapy after hematopoietic stem cell transplant in children: results of a prospective randomized trial.
Dallorso S; Rondelli R; Messina C; Pession A; Giorgiani G; Fagioli F; Locatelli F; Manzitti C; Balduzzi A; Prete A; Cesaro S; Lanino E; Dini G
Haematologica; 2002 Dec; 87(12):1274-80. PubMed ID: 12495901
[TBL] [Abstract][Full Text] [Related]
9. Reduced risk of acute GVHD following mobilization of HLA-identical sibling donors with GM-CSF alone.
Devine SM; Brown RA; Mathews V; Trinkaus K; Khoury H; Adkins D; Vij R; Sempek D; Graubert T; Tomasson M; Goodnough LT; DiPersio JF
Bone Marrow Transplant; 2005 Sep; 36(6):531-8. PubMed ID: 16025152
[TBL] [Abstract][Full Text] [Related]
10. Clinical evidence for an engraftment syndrome associated with early and steep neutrophil recovery after autologous blood stem cell transplantation.
Ravoet C; Feremans W; Husson B; Majois F; Kentos A; Lambermont M; Wallef G; Capel P; Beauduin M; Delannoy A
Bone Marrow Transplant; 1996 Nov; 18(5):943-7. PubMed ID: 8932849
[TBL] [Abstract][Full Text] [Related]
11. Engraftment syndrome following autologous hematopoietic stem cell transplantation: definition of diagnostic criteria.
Maiolino A; Biasoli I; Lima J; Portugal AC; Pulcheri W; Nucci M
Bone Marrow Transplant; 2003 Mar; 31(5):393-7. PubMed ID: 12634731
[TBL] [Abstract][Full Text] [Related]
12. Enhanced antileukemic activity of allogeneic peripheral blood progenitor cell transplants following donor treatment with the combination of granulocyte colony-stimulating factor (G-CSF) and stem cell factor (SCF) in a murine transplantation model.
Hartung G; Zeis M; Glass B; Dreger P; Steinmann J; Schmitz N; Uharek L
Bone Marrow Transplant; 2003 Jul; 32(1):49-56. PubMed ID: 12815478
[TBL] [Abstract][Full Text] [Related]
13. A randomized, multicenter study of G-CSF starting on day +1 vs day +5 after autologous peripheral blood progenitor cell transplantation.
de Azevedo AM; Nucci M; Maiolino A; Vigorito AC; Simões BP; Aranha FJ; Tabak DG; Voltarelli J; de Souza CA
Bone Marrow Transplant; 2002 May; 29(9):745-51. PubMed ID: 12040471
[TBL] [Abstract][Full Text] [Related]
14. Granulocyte colony-stimulating factor alone at 12 microg/kg twice a day for 4 days for peripheral blood progenitor cell priming in pediatric patients.
Sevilla J; González-Vicent M; Madero L; García-Sánchez F; Díaz MA
Bone Marrow Transplant; 2002 Oct; 30(7):417-20. PubMed ID: 12368952
[TBL] [Abstract][Full Text] [Related]
15. Comparative cost analysis of autologous peripheral blood progenitor cell and bone marrow transplantation in pediatric patients with malignancies.
Vicent MG; Madero L; Chamorro L; Madero R; Diaz MA
Haematologica; 2001 Oct; 86(10):1087-94. PubMed ID: 11602415
[TBL] [Abstract][Full Text] [Related]
16. Role of antithymocyte globulin and granulocyte-colony stimulating factor-mobilized bone marrow in allogeneic transplantation for patients with hematologic malignancies.
Chen XH; Zhang C; Zhang X; Gao L; Gao L; Kong PY; Peng XG; Qi DG; Sun AH; Zeng DF; Liu H; Gong Y; Wang QY
Biol Blood Marrow Transplant; 2009 Feb; 15(2):266-73. PubMed ID: 19167687
[TBL] [Abstract][Full Text] [Related]
17. An engraftment syndrome in autologous stem cell transplantation related to mononuclear cell dose.
Edenfield WJ; Moores LK; Goodwin G; Lee N
Bone Marrow Transplant; 2000 Feb; 25(4):405-9. PubMed ID: 10723584
[TBL] [Abstract][Full Text] [Related]
18. Factors influencing engraftment in autologous peripheral hematopoetic stem cell transplantation (PBSCT).
Ergene U; Cağirgan S; Pehlivan M; Yilmaz M; Tombuloğlu M
Transfus Apher Sci; 2007 Feb; 36(1):23-9. PubMed ID: 17292672
[TBL] [Abstract][Full Text] [Related]
19. Reduced dose of lenograstim is as efficacious as standard dose of filgrastim for peripheral blood stem cell mobilization and transplantation: a randomized study in patients undergoing autologous peripheral stem cell transplantation.
Ataergin S; Arpaci F; Turan M; Solchaga L; Cetin T; Ozturk M; Ozet A; Komurcu S; Ozturk B
Am J Hematol; 2008 Aug; 83(8):644-8. PubMed ID: 18508321
[TBL] [Abstract][Full Text] [Related]
20. Engraftment syndrome following allogeneic hematopoietic stem cell transplantation in children.
Nishio N; Yagasaki H; Takahashi Y; Hama A; Muramatsu H; Tanaka M; Yoshida N; Yoshimi A; Kudo K; Ito M; Kojima S
Pediatr Transplant; 2009 Nov; 13(7):831-7. PubMed ID: 19067915
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
